SANGUINE CORPORATION & SUBSIDIARY (A Development Stage Company) Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2012	Dec. 31, 2011
CURRENT ASSETS
Cash	$ 1,858	$ 1,436
Total Current Assets	1,858	1,436
PROPERTY AND EQUIPMENT, NET	239	284
TOTAL ASSETS	2,097	1,720
CURRENT LIABILITIES
Accounts payable	254,371	261,814
Accrued interest	20,059	14,539
Related party payable	407,641	357,641
Convertible promissory notes payable, net of debt discounts of $49,778 and $64,461, respectively	157,422	121,739
Total Current Liabilities	839,493	755,733
Total Liabilities	839,493	755,733
COMMITMENTS AND CONTINGENCIES	0	0
SHAREHOLDERS' DEFICIT
Preferred stock, 10,000,000 shares authorized of $0.001 par value, 75,000 and 150,000 shares issued and outstanding, respectively	75	75
Common stock, 200,000,000 shares authorized of $0.001 par value, 7,246,822 and 6,682,072 shares issued and outstanding, respectively	7,247	7,247
Additional paid in capital	9,820,611	9,817,416
Deficit accumulated during the development stage	(10,665,329)	(10,578,751)
Total Shareholders' Deficit	(837,396)	(754,013)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 2,097	$ 1,720